Hagar Labouta
Associate Professor, University of Toronto; Keenan Professor in Medical Discovery, Unity Health Toronto
From Nanoparticles to Humanized Organ-on-a-Chip Models: Data-Driven Platforms for Drug Discovery
Learning objectives
- Define prenatal nanomedicine and RNA-loaded nanoparticle design
- Explain 3D microfluidic chip strategies for scalable nanoparticle production
- Evaluate pregnancy-on-chip and fetal models for prenatal screening
Speaker Bio
Hagar Labouta is Associate Professor at the University of Toronto at the Leslie Dan Faculty of Pharmacy and the Institute of Biomedical Engineering, and Keenan Professor of Medical Discovery at Unity health Toronto and. She received her Ph.D. in pharmaceutical nanotechnology from Saarland University (Germany) and completed Postdocs at Helmholtz institute (Germany), and University of Calgary (Canada). Her team uses nanotechnology, microfluidics and organ-on-a-chip models to develop novel therapies for Women’s Health. She has won several awards including Rising Women in Science and Member of the Year Award from the Controlled Release Society, Early Career NanoOntario Award from NanoOntario and Interstellar Award from New York Academy of Sciences.
Registration
The seminar will be held by Zoom on December 1, 2026 at 11am EST. Please use this Google Forms link to register.